Clover Health Business Model Canvas

PBM partnerships manage formularies, negotiate prices, and run adherence programs that target the three CMS Part D medication adherence Star measures (2024), reducing drug spend and nonadherence. Lab/diagnostic partners deliver rapid results to point of care, enabling real-time medication management and gap closure. These coordinated services drive better clinical outcomes and higher Star ratings.

Contracts with providers secure network access; Medicare Advantage enrollment >31M in 2024 underscores scale. Tech/EHR partners power Clover Assistant analytics and HIPAA security. PBM, labs and reinsurers (attachment $250k–$1M) reduce cost and support Star metrics. Community groups and FMOs extend distribution and retention.

Deploy Clover Assistant at point of care to deliver real-time decision support, reducing delays in clinical decisions and standardizing care across clinics in 2024.

Train clinics and integrate the Assistant with EHRs and workflows to ensure adoption and minimize disruption to clinician workflows.

Align provider incentives with value-based contracts and monitor performance through actionable analytics dashboards that feed back into care pathways.

Design MA benefits/networks/formularies to achieve 4+ Stars, bidding to CMS with risk‑adjusted forecasts (Medicare Advantage >30M enrollees in 2024). Deploy Clover Assistant for care‑gap closure, real‑time EHR decision support and population health analytics. Manage CMS submissions, HCC risk adjustment, HEDIS/CAHPS/Stars reporting and HIPAA compliance; drive enrollment via brokers and digital channels.

Contracted networks span primary, specialty and facility care to ensure continuum of services; value-based arrangements and shared-incentive contracts align provider payment with outcomes. Clinical liaisons and enablement teams operationalize care pathways and reduce utilization. Emphasis on trust and access targets underserved communities within a Medicare Advantage market exceeding 30 million enrollees in 2024.

Clover’s proprietary Clover Assistant and 10+ years of longitudinal member data power real-time risk stratification, gap closure and value-based care workflows across its Medicare Advantage footprint.

Key resources include MA licenses/CMS contracts, capital reserves and reinsurance, specialist teams (actuarial, clinical, data science, engineering) and broker/member operations.

Interoperability pipelines, vendor partnerships and compliance controls (HIPAA/SOC) secure data and support scale into a MA market >30 million enrollees in 2024.

Clover Assistant surfaces risks, medications, and evidence-based recommendations directly in clinician workflows, enabling faster decisions and more timely interventions. By reducing administrative friction—fewer clicks and consolidated views—clinicians can reallocate time to care. Integrated claims and EMR data improves completeness and accuracy, supporting care coordination as Medicare Advantage enrollment exceeded 30 million in 2024.

Data-driven care closes gaps and reduces avoidable events; Clover served about 100,000 Medicare Advantage members in 2024 and leverages real-time insights at point of care. Affordable MA plans, supplemental benefits and pharmacy programs support retention and cost control while MA enrollment reached ~31 million in 2024.

Provider enablement combines structured training, rapid onboarding, and ongoing support for Clover Assistant to drive adoption and workflow integration in 2024. Real-time data sharing and quarterly performance reviews benchmark utilization and outcomes. Dedicated liaisons triage workflow issues and optimize care paths. Incentive programs tie payments to agreed quality and cost-saving targets.

Clover Health delivers multichannel member support (phone, app, portal, in-person) with proactive outreach and personalized care management to close gaps. Assigned care managers coordinate high-risk care across ~419,000 Medicare Advantage members (2024) and social-needs referrals. Broker and local outreach sustain enrollments in a 30.5M MA market (2024) with ~85% retention.

PCPs introduce eligible patients to Clover plan options at point-of-care, supported by in-clinic materials and staff prompts to boost awareness. Point-of-care credibility from trusted clinicians materially increases conversion; Medicare Advantage enrollment exceeded 30 million in 2024 per CMS, highlighting market scale. Seamless handoffs to dedicated enrollment teams close the loop and improve enrollment velocity.

Brokers, digital, PCP referrals, community events and Medicare.gov/aggregators jointly drive Clover Health MA acquisition and retention, with brokers concentrated in AEP (Oct 15–Dec 7) and OEP (Jan 1–Mar 31). Digital tools and real-time data capture increase conversions; PCP handoffs and local ambassadors boost uptake in underserved zip codes. Medicare Advantage market ≈30–31M enrollees in 2024, raising shopper activity.

Members with diabetes (37.3M US, CDC 2023), CHF and COPD within Medicare Advantage (30.6M enrollees in 2024, CMS) often present multi-morbidity—over 60% of Medicare beneficiaries have two+ chronic conditions (CMS). They gain from proactive monitoring and gap-closure, need medication management and frequent follow-ups, and show high outcome/cost impact from real-time insights.

Primary: 65+ Medicare Advantage enrollees ~30M of 57M seniors (2024); prioritize affordability, provider access, supplemental benefits.

High-need: dual-eligibles ~12M (2024) and seniors with multi-morbidity (~60% with 2+ chronic conditions); need care coordination and medication management.

Caregivers (~53M) and providers drive choice and retention; clinicians use point-of-care tools to improve quality and reduce costs.

Operations & admin at Clover centers on member services, claims/billing, and compliance, driving fixed and variable costs; in 2024 Medicare Advantage enrollment topped 30 million, increasing claims volume and broker commissions (commissions often 2–3% of premium). Licensing, audit and legal inflate compliance spend, while facilities and admin staffing form the bulk of SG&A.

Medical claims are Clover’s largest cost driver, with Medicare Advantage MLRs ~85–90% in 2023–2024 and pharmacy ~15–25% of claim spend; managed via networks, value‑based contracts and care programs. Provider enablement, integrations and data platforms create sizable tech and implementation costs. SG&A covers member services, compliance, broker commissions (2–3% of premium) and marketing tied to MA growth.

Star ratings generate CMS quality bonus payments and increase rebate shares to plans; in 2024 Medicare Advantage enrollment topped about 30 million, making these bonuses material to revenue. Higher Stars directly uplift plan benchmarks and rebate pools, incentivizing improved patient experience, adherence, and outcomes. This structure reinforces Clover's investment in care management and risk-based programs to capture bonus-driven revenue.

CMS capitation (risk-adjusted PMPM) is Clover’s primary revenue, driven by CMS-HCC scores and accurate documentation; Medicare Advantage enrollment ~30.3 million in 2024 expands the addressable market. Star bonuses and rebates materially boost revenue and margins, while pharmacy rebates and investment income further lower net medical cost. Clover Assistant and audits increased HCC capture in 2024, raising PMPM revenue.